ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma

Chen, Riyu; Guan, Zeyi; Zhong, Xianxing; Zhang, Wenzheng*; Zhang, Ya*广州中医药大学; 南方医科大学; 山东省医学科学院; y
Computational and Mathematical Methods in Medicine2022-1-13DOI: 10.1155/2022/3197402
6被引5阅读
引用收藏
分享

摘要

Objective. To explore the active compounds and targets of cinobufotalin (huachansu) compared with the osteosarcoma genes to obtain the potential therapeutic targets and pharmacological mechanisms of action of cinobufotalin on osteosarcoma through network pharmacology. Methods. The composition of cinobufotalin was searched by literature retrieval, and the target was selected from the CTD and TCMSP databases. The osteosarcoma genes, found from the GeneCards, OMIM, and other databases, were compared with the cinobufotalin targets to obtain potential therapeutic targets. The protein-protein interaction (PPI) network of potential therapeutic targets, constructed through the STRING database, was inputted into Cytoscape software to calculate the hub genes, using the NetworkAnalyzer. The hub genes were inputted into the Kaplan-Meier Plotter online database for exploring the survival curve. Functional enrichment analysis was identified using the DAVID database. Results. 28 main active compounds of cinobufotalin were explored, including bufalin, adenosine, oleic acid, and cinobufagin. 128 potential therapeutic targets on osteosarcoma are confirmed among 184 therapeutic targets form cinobufotalin. The hub genes included TP53, ACTB, AKT1, MYC, CASP3, JUN, TNF, VEGFA, HSP90AA1, and STAT3. Among the hub genes, TP53, ACTB, MYC, TNF, VEGFA, and STAT3 affect the patient survival prognosis of sarcoma. Through function enrichment analysis, it is found that the main mechanisms of cinobufotalin on osteosarcoma include promoting sarcoma apoptosis, regulating the cell cycle, and inhibiting proliferation and differentiation. Conclusion. The possible mechanisms of cinobufotalin against osteosarcoma are preliminarily predicted through network pharmacology, and further experiments are needed to prove these predictions.

学科与关键词

关键词
APOPTOSISBUFALINCELLSAUTOPHAGYPATHWAY
相关
加载中…
  • Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma
    Huang, Renxuan; Xu, Mingxian; Guo, Weitang; Cheng, Mingzhe; Dong, Rui; Tu, Jian; Xu, Shao*; Zou, Changye*Cancer Cell International, 2023, 23(1): 213.被引 1
  • Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology
    Chen, Lizhi; Zhou, Yue; Weng, Zheng; Liu, Shuang; Li, Ting; Wang, Yanfang; Yang, Yang; Liu, Hongmei*; Huang, Wenhua*Aging-US, 2023, 15(20): 11489-11507.
  • Identification and Analysis of Three Hub Prognostic Genes Related to Osteosarcoma Metastasis
    Tan, Jianye; Liang, Haofeng; Yang, Bingsheng; Zhu, Shuang; Wu, Guofeng; Li, Lutao; Liu, Zhengwei; Li, Lin; Qi, Weizhong; Li, Sijing; Lin, LijunJournal of Oncology, 2021, 2021: 6646459.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Computational and Mathematical Methods in Medicine
发表日期
2022-01-13
卷期
第 2022 卷
页码
3197402
DOI
10.1155/2022/3197402
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • C

    Chen, Riyu (第一作者)

    guangzhou univ chinese med

  • G

    Guan, Zeyi

    southern med univ

查看全部 5 位作者收起作者
  • Z

    Zhong, Xianxing

    guangzhou univ chinese med

  • Z

    Zhang, Wenzheng (通讯)

    shandong acad med sci · taian city cent hosp

  • Z

    Zhang, Ya (通讯)

    2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417